Pubblicazioni

Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer's disease: relevance for precision medicine in neurodegenerative diseases

2023 - AGEING RESEARCH REVIEWS

Lista, Simone; Vergallo, Andrea; Teipel, Stefan J; Lemercier, Pablo; Giorgi, Filippo Sean; Gabelle, Audrey; Garaci, Francesco; Mercuri, Nicola B; Babiloni, Claudio; Gaire, Bhakta Prasad; Koronyo, Yosef; Koronyo-Hamaoui, Maya; Hampel, Harald; NisticÃ², Robert

Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease

2022 - JOURNAL OF ALZHEIMER'S DISEASE

Crestini, A.; Santilli, F.; Martellucci, S.; Carbone, E.; Sorice, M.; Piscopo, P.; Mattei, V.

Alzheimer disease and neuroplasticity

2022 - Handbook of Clinical Neurophysiology

Koch, Giacomo; Spampinato, Danny Adrian

Paraoxonase-1 and-3 protein expression in the brain of the tg2576 mouse model of alzheimerâs disease

2021 - ANTIOXIDANTS

Salazar, J. G.; Marsillach, J.; Reverte Soler, Ingrid; Mackness, B.; Mackness, M.; Joven, J.; Camps, J.; Colomina, M. T.

The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease

2015 - JOURNAL OF ALZHEIMER'S DISEASE

Bedse, Gaurav; Romano, Adele; Lavecchia, ANGELO MICHELE; Cassano, T; Gaetani, Silvana